Healthcare -
Drug Manufacturers - General - NYSE - US
$ 211.93
1.39 %
$ 374 B
Market Cap
89.05
P/E
Price Target
Average
--4.07%
Revenue Forecast
Estimate
7.83%
EBIT
Estimate
22.30%
Net Income
Estimate
66.20%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
AbbVie Inc.
Wall Street analysts predict an average 1-year price target for ABBV of $203 , with forecasts ranging from
a
low of
$175 to a high of $228 .
ABBV Lowest Price Target
Wall Street Target
175 USD
-17.43%
ABBV Average Price Target
Wall Street Target
203 USD
-4.07%
ABBV Highest Price Target
Wall Street Target
228 USD
7.58%
REVENUE FORECAST
Revenue Forecast Chart ABBV
EBIT FORECAST
EBIT Forecast Chart ABBV
NET INCOME FORECAST
Net Income Chart ABBV